Bottom line
How much do PRHSX and JDOC overlap?
58% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 49.6% of PRHSX's assets and 52.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 61), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and JDOC have in common
| Holding | % of PRHSX | % of JDOC | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 7.76% | 7.76% |
| Johnson & Johnson | 6.63% | 4.82% | 4.82% |
| Unitedhealth Group Inc | 5.99% | 5.85% | 5.85% |
| Abbvie Inc | 5.10% | 7.85% | 5.10% |
| Merck & Co. Inc. | 4.01% | 4.82% | 4.01% |
| Thermo Fisher Scientific Inc | 2.52% | 3.73% | 2.52% |
| Bristol-myers Squibb Co | 2.11% | 3.57% | 2.11% |
| Abbott Laboratories | 1.89% | 3.11% | 1.89% |
| Intuitive Surgical Inc | 1.87% | 1.93% | 1.87% |
| Stryker Corp | 1.78% | 2.23% | 1.78% |
| Danaher Corp | 1.43% | 2.16% | 1.43% |
| Cardinal Health Inc | 1.03% | 1.51% | 1.03% |
| Cvs Health Corp | 0.94% | 2.83% | 0.94% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Gilead Sciences Inc — 2.82%
- Vertex Pharmaceuticals Inc — 2.28%
- Amgen Inc — 1.82%
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.23%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
- Brightspring Health Services — 0.82%
Only in JDOC
- AstraZeneca plc — 3.76%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Regeneron Pharmaceuticals, Inc. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
Asset mix
| Asset type | PRHSX | JDOC |
|---|---|---|
| Stocks | 96.4% | 99.2% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 0.7% | — |
| Bonds | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | PRHSX | JDOC |
|---|---|---|
| US | 92.6% | 75.2% |
| GB | 1.7% | 6.2% |
| CH | 0.5% | 4.4% |
| DK | 0.7% | 4.0% |
| JP | 0.5% | 2.5% |
| NL | 1.0% | 2.4% |
| DE | — | 1.9% |
| IL | 0.2% | 1.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PRHSX and JDOC overlap?
What stocks do PRHSX and JDOC have in common?
Should I own both PRHSX and JDOC?
Which holds more stocks, PRHSX or JDOC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.